Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
72.45
+1.34 (1.88%)
At close: Mar 5, 2026, 4:00 PM EST
72.00
-0.45 (-0.62%)
Pre-market: Mar 6, 2026, 8:57 AM EST
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 129.83, with a low estimate of 90 and a high estimate of 165. The average target predicts an increase of 79.20% from the current stock price of 72.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $105 → $150 | Strong Buy | Reiterates | $105 → $150 | +107.04% | Feb 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $165 | Strong Buy | Maintains | $135 → $165 | +127.74% | Feb 10, 2026 |
| BTIG | BTIG | Strong Buy Maintains $118 → $151 | Strong Buy | Maintains | $118 → $151 | +108.42% | Feb 10, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $118 | Strong Buy | Reiterates | $118 | +62.87% | Jan 29, 2026 |
| BTIG | BTIG | Strong Buy Maintains $100 → $118 | Strong Buy | Maintains | $100 → $118 | +62.87% | Dec 16, 2025 |
Financial Forecast
Revenue This Year
44.66M
from 98.43M
Decreased by -54.63%
Revenue Next Year
42.69M
from 44.66M
Decreased by -4.42%
EPS This Year
-10.35
from -8.68
EPS Next Year
-9.81
from -10.35
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 51.7M | 57.2M | ||||
| Avg | 44.7M | 42.7M | ||||
| Low | 39.2M | 23.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -47.5% | 28.0% | ||||
| Avg | -54.6% | -4.4% | ||||
| Low | -60.2% | -47.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -10.20 | -7.01 | |||
| Avg | -10.35 | -9.81 | |||
| Low | -10.66 | -11.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.